Shree Rama Multi-Tech tubing capacity is set to rise by 1.15 crore tubes a month after a new machine began commercial production at the company’s Moti-Bhoyan plant in Gujarat on September 21. The ₹20 crore internally funded addition addresses a disclosed 90% utilisation rate, but its financial benefit still depends on orders, utilisation and product mix.
What changed in Shree Rama Multi-Tech tubing capacity
The company’s Regulation 30 disclosure, indexed by Shree Rama Multi-Tech’s BSE filing, records the start of commercial production at the Moti-Bhoyan plant. EquityBulls independently reported that tubes of different sizes and dimensions began production on September 21 after the required trials and quality checks.
ScanX reported existing capacity of 7.70 crore tubes a month and the addition of 1.15 crore. That implies indicated capacity of 8.85 crore tubes per month, a roughly 14.9% increase. The arithmetic is derived from disclosed figures; actual production will depend on utilisation.
Why a production start matters
A machine becoming commercially operational is a stronger milestone than a plan to install capacity. It means commissioning and trials have advanced far enough for sellable production to begin. The disclosure says the new line uses updated technology for laminated tubes, which serve oral-care, pharmaceutical, cosmetics and fast-moving consumer-goods packaging.
The company reported 90% utilisation of existing tube capacity, so the extra line can relieve a bottleneck if demand continues. Internal-accrual funding also means the stated ₹20 crore capital cost did not require a new project-specific borrowing in the disclosure. That does not make the investment risk-free: maintenance, raw materials, quality yields and customer qualification still affect returns.
In plain terms: Shree Rama Multi-Tech tubing capacity has moved from installation to production, but the commercial result will be measured by how quickly the new 1.15 crore monthly capacity fills with profitable customer orders.
Capacity does not automatically equal revenue
The company expects the machine to support future topline and bottom-line growth, but the announcement does not quantify committed orders, selling prices, operating margin or the ramp schedule. Even at a plant already running at high utilisation, a new line may take time to reach steady output as customers approve specifications and the operator tunes quality and speed.
The useful comparison is with other capacity stories tracked by Lapaas Voice. Transrail’s completed conductor-capacity expansion similarly shifted focus from capex to utilisation. Lord’s Mark’s completed Silvassa expansion shows why throughput, distribution and demand must work together after equipment is installed.
What to watch next
Investors should watch production volumes, capacity utilisation and segment revenue over the next two results cycles. Gross margin and power, polymer and laminate input costs will show whether higher output improves operating leverage or merely adds volume.
Customer concentration and working capital also matter. Packaging manufacturers often carry receivables and inventory while serving large consumer and healthcare clients. A faster line creates value when incremental contribution exceeds depreciation, operating costs and additional working-capital needs.
The September 21 milestone is auditable and operationally relevant. It should be read as the start of the return-on-capital test, not its conclusion.
FAQs
How much capacity does the new machine add?
The company disclosed proposed capacity of 1.15 crore tubes per month.
What is the indicated total monthly capacity?
Adding 1.15 crore to the disclosed existing 7.70 crore gives an indicated 8.85 crore tubes per month.
How was the expansion funded?
The ₹20 crore capital investment was funded through internal accruals, according to the company disclosure.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
